Teacher Retirement System of Texas purchased a new stake in Sotera Health Company (NASDAQ:SHC - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 22,774 shares of the company's stock, valued at approximately $266,000.
A number of other institutional investors have also recently made changes to their positions in the business. Sculptor Capital LP purchased a new position in Sotera Health in the fourth quarter worth $68,400,000. Two Seas Capital LP grew its holdings in Sotera Health by 624.0% in the fourth quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock worth $39,619,000 after purchasing an additional 2,496,136 shares during the last quarter. D. E. Shaw & Co. Inc. grew its holdings in Sotera Health by 140.8% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,624,750 shares of the company's stock worth $35,907,000 after purchasing an additional 1,534,666 shares during the last quarter. Ananym Capital Management LP purchased a new position in Sotera Health in the fourth quarter worth $13,680,000. Finally, Norges Bank purchased a new position in Sotera Health in the fourth quarter worth $12,764,000. Institutional investors own 91.03% of the company's stock.
Sotera Health Trading Up 4.3%
Shares of NASDAQ SHC traded up $0.49 during trading on Wednesday, hitting $11.85. 1,311,914 shares of the company traded hands, compared to its average volume of 1,237,256. Sotera Health Company has a 1 year low of $9.53 and a 1 year high of $17.08. The company has a 50-day moving average price of $11.78 and a 200-day moving average price of $12.15. The firm has a market capitalization of $3.36 billion, a P/E ratio of 148.14 and a beta of 1.81. The company has a quick ratio of 2.19, a current ratio of 2.46 and a debt-to-equity ratio of 5.55.
Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. The company had revenue of $254.52 million during the quarter, compared to analyst estimates of $245.56 million. Sotera Health had a net margin of 2.24% and a return on equity of 41.08%. The firm's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the business earned $0.13 EPS. On average, equities analysts predict that Sotera Health Company will post 0.61 EPS for the current year.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the stock. Piper Sandler cut their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Barclays dropped their price objective on shares of Sotera Health from $15.00 to $13.00 and set an "overweight" rating for the company in a research note on Tuesday, June 24th. Wall Street Zen raised shares of Sotera Health from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Finally, The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $14.00 to $17.00 in a research note on Monday, May 5th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $16.00.
Read Our Latest Stock Report on SHC
Sotera Health Profile
(
Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Articles

Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.